| Nimi | Vol. | Hinta | |
|---|---|---|---|
NOVOb Novo Nordisk A/S Class B | 2,37M | 687,10-0,74% | 05/12 |
BIOPOR Bioporto | 1,03M | 2,26-3,83% | 05/12 |
HLUNb H Lundbeck B | 598,5K | 32,50-0,91% | 05/12 |
BAVA Bavarian Nordic | 525,45K | 172,90+4,60% | 05/12 |
NZYMb Novozymes A/S B | 447,6K | 353,70-1,12% | 05/12 |
| Nimi | Hinta | |
|---|---|---|
BAVA Bavarian Nordic | 172,90 | +7,6 | +4,60%
ORPHA Orphazyme | 0,74 | +0,02 | +2,64%
ZELA Zealand Pharma | 344,80 | +4,40 | +1,29%
ALKb Alk Abello | 93,25 | +1,05 | +1,14%
GUBRA Gubra AS | 116,00 | +0,94 | +0,82%
| Nimi | Hinta | |
|---|---|---|
BIOPOR Bioporto | 2,26 | -0,090 | -3,83%
NZYMb Novozymes B | 353,70 | -4,0 | -1,12%
CHRH Chr Hansen | 541,00 | -6,0 | -1,10%
PEGRP Pharma Equity AS | 0,42 | -0,004 | -0,94%
HLUNb H Lundbeck B | 32,50 | -0,30 | -0,91%